| Assaying the Effects of Splice Site Variants by Exon Trapping in a Mammalian Cell Line
|
|
Author:
Date:
2017-05-20
[Abstract] There are several in silico programs that endeavor to predict the functional impact of an individual’s sequence variation at splice donor/acceptor sites, but experimental confirmation is problematic without a source of RNA from the individual that carries the variant. With the aid of an exon trapping vector, such as pSPL3, an investigator can test whether a splice site sequence change leads to altered RNA splicing, through expression of reference and variant mini-genes in mammalian cells and analysis of the resultant RNA products.
[摘要] 有几个计算机程序尝试预测个体在剪接供体/受体位点的序列变异的功能影响，但实验确认是有问题的，没有携带变体的个体的RNA来源。借助于外显子捕获载体，例如pSPL3，研究人员可以通过在哺乳动物细胞中表达参考和变体小基因来测试剪接位点序列变化是否导致改变的RNA剪接，并分析所得RNA产物。
背景 我们希望通过实验测试在TEK基因中鉴定的两个剪接供体位点变体c.760 + 2T> C和c.3300 + 2delT的功能影响（Souma等人，2016）。通常情况下，携带这些序列变体的个体不能获得细胞或mRNA的样品，因此我们利用外显子捕获方法作为功能测试。来自患者的DNA样品可用于感兴趣的基因组区域的PCR扩增。如果患者gDNA样品不可用，也可以通过诸如基于PCR的定点诱变等方法将序列变体并入野生型序列。
＆NBSP;外显子捕获方法最初是为了鉴定长期基因组DNA中的未知外显子而开发的（Duyk等人，1990）。创建了pSPL3外显子捕获载体以提高外显子鉴定的效率和可靠性，并且还允许筛选更大的基因组片段（Church et al。，1994; Nisson等，1994）。 pSPL3载体含有由SV40启动子组成的小型人造基因，具有功能性剪接供体和受体位点的外显子 - 内含子 - ...
|
|
|
| Endogenous C-terminal Tagging by CRISPR/Cas9 in Trypanosoma cruzi
|
|
Author:
Date:
2017-05-20
[Abstract] To achieve the C-terminal tagging of endogenous proteins in T. cruzi we use the Cas9/pTREX-n vector (Lander et al., 2015) to insert a specific tag sequence (3xHA or 3xc-Myc) at the 3’ end of a specific gene of interest (GOI). Chimeric sgRNA targeting the 3’ end of the GOI is PCR-amplified and cloned into Cas9/pTREX-n vector. Then a DNA donor molecule to induce DNA repair by homologous recombination is amplified. This donor sequence contains the tag sequence and a marker for antibiotic resistance, plus 100 bp homology arms corresponding to regions located right upstream of the stop codon and downstream of the Cas9 target site at the GOI locus. Vectors pMOTag23M (Oberholzer et al., 2006) or pMOHX1Tag4H (Lander et al., 2016b) are used as PCR templates for ...
[摘要] 为了实现克氏锥虫内源蛋白的C末端标记，我们使用Cas9 / pTREX-n载体（Lander等，2015）在3'末端插入特异性标签序列（3xHA或3xc-Myc）特定的感兴趣基因（GOI）。将靶向GOI 3'末端的嵌合sgRNA进行PCR扩增，并克隆到Cas9 / pTREX-n载体中。然后扩增通过同源重组诱导DNA修复的DNA供体分子。该供体序列包含标签序列和抗生素抗性标记，加上对应于位于终止密码子右上游的区域和在GOI基因座的Cas9靶位点下游的100bp同源臂。载体pMOTag23M（Oberholzer等，2006）或pMOHX1Tag4H（Lander等，2016b）用作DNA供体扩增的PCR模板。用sgRNA / Cas9 / pTREX-n构建体和DNA供体盒共转染的Epimastigotes然后用抗生素培养5周以选择双重抗性寄生虫。最终通过PCR和Western印迹分析验证了内源基因标记。
【背景】自从CRISPR / ...
|
|
|
| Individual-nucleotide-resolution UV Cross-linking and Immunoprecipitation (iCLIP) of UPF1
|
|
Author:
Date:
2014-04-05
[Abstract] The fate of mRNA, in particular its stability, localization and rate of translation is regulated by RNA binding proteins assembling to messenger ribonucleoprotein (mRNP) complexes. To investigate the transcriptome-wide RNA binding sites of UPF1, the core factor of nonsense-mediated mRNA decay (NMD), we performed individual-nucleotide-resolution UV cross-linking and immunoprecipitation (iCLIP) (Zund et al., 2013) followed by high-throughput sequencing. The presented protocol is optimized to investigate the RNA-binding sites of UPF1 and is based on previously described studies (Konig et al., 2010; Konig et al., 2011; Hafner et al., 2010). We want to thank the Group of Mihaela Zavolan (Swiss Institute of Bioinformatics, Basel, Switzerland) and Jernej Ule ...
[摘要] mRNA的命运，特别是其稳定性，定位和翻译速率由装配到信使核糖核蛋白（mRNP）复合物的RNA结合蛋白调节。 为了研究无义介导的mRNA衰变（NMD）的核心因子UPF1的转录组范围的RNA结合位点，我们进行单个核苷酸分辨率的UV交联和免疫沉淀（iCLIP）（Zund等，/em>，2013），然后进行高通量测序。 优化所提出的方案以研究UPF1的RNA结合位点并且基于先前描述的研究（Konig等人，2010; Konig等人，2011; Hafner等人，2010）。 我们要感谢Mihaela Zavolan（瑞士巴塞尔瑞士生物信息学研究所）和Jernej Ule（英国剑桥的分子生物学医学研究委员会实验室）组织这些实验的技术支持。
|
|
|